Pharnext Financials
| ALPHA Stock | EUR 0.0002 0.00 0.00% |
Pharnext |
Understanding current and past Pharnext Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Pharnext's financial statements are interrelated, with each one affecting the others. For example, an increase in Pharnext's assets may result in an increase in income on the income statement.
Pharnext Stock Summary
Pharnext competes with Kaufman Et, Les Hotels, Gaztransport Technigaz, Eutelsat Communications, and Broadpeak. Pharnext SA, a clinical-stage biopharmaceutical company, develops therapeutics for severe orphan and common neurodegenerative diseases in France. The company was founded in 2007 and is based in Issy-Les-Moulineaux, France. Pharnext S is traded on Paris Stock Exchange in France.| Instrument | France Stock View All |
| Exchange | Euronext Paris |
| ISIN | FR0011191287 |
| Business Address | Immeuble Vivaldi, Issy-les-Moulineaux, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.pharnext.com |
| Phone | 33 1 41 09 22 30 |
| Currency | EUR - Euro |
You should never invest in Pharnext without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Pharnext Stock, because this is throwing your money away. Analyzing the key information contained in Pharnext's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Pharnext Key Financial Ratios
Pharnext's financial ratios allow both analysts and investors to convert raw data from Pharnext's financial statements into concise, actionable information that can be used to evaluate the performance of Pharnext over time and compare it to other companies across industries.| Return On Equity | -13.48 | |||
| Return On Asset | -0.76 | |||
| Target Price | 12500.0 | |||
| Number Of Employees | 28 | |||
| Beta | 1.24 |
Pharnext Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pharnext's current stock value. Our valuation model uses many indicators to compare Pharnext value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pharnext competition to find correlations between indicators driving Pharnext's intrinsic value. More Info.Pharnext SA is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pharnext's earnings, one of the primary drivers of an investment's value.Pharnext SA Systematic Risk
Pharnext's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Pharnext volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Pharnext SA correlated with the market. If Beta is less than 0 Pharnext generally moves in the opposite direction as compared to the market. If Pharnext Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Pharnext SA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Pharnext is generally in the same direction as the market. If Beta > 1 Pharnext moves generally in the same direction as, but more than the movement of the benchmark.
Additional Tools for Pharnext Stock Analysis
When running Pharnext's price analysis, check to measure Pharnext's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharnext is operating at the current time. Most of Pharnext's value examination focuses on studying past and present price action to predict the probability of Pharnext's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharnext's price. Additionally, you may evaluate how the addition of Pharnext to your portfolios can decrease your overall portfolio volatility.